
Hypercoagulability, estrogen-associated: Hypercoagulability (a supranormal tendency for blood to clot) occurs as an occasional but serious side effect of estrogen therapy. The <a href="https://www.medicinenet.com/blood_clots/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">blood clots</a> in this situation are dose-related, that is, they occur more frequently with higher doses of estrogen.
Estrogen therapy preparations (all of which carry this risk) include:<ul>
<li>esterified <a href="https://www.medicinenet.com/estrogens_conjugated-vaginal_cream/article.htm" onclick="wmdTrack('embd-lnk');" rel="pharm">estrogens</a></li>
<li><a href="https://www.medicinenet.com/esterified_estrogens_and_methyltestosterone/article.htm" onclick="wmdTrack('embd-lnk');" rel="pharm">esterified estrogens and methyltestosterone</a></li>
<li><a href="https://www.medicinenet.com/estradiol/article.htm" onclick="wmdTrack('embd-lnk');" rel="pharm">estradiol</a></li>
<li>estrogens (conjugated) and <a href="https://www.medicinenet.com/medroxyprogesterone/article.htm" onclick="wmdTrack('embd-lnk');" rel="pharm">medroxyprogesterone</a></li>
<li><a href="https://www.medicinenet.com/estrogens_conjugated/article.htm" onclick="wmdTrack('embd-lnk');" rel="pharm">estrogens conjugated</a></li>
</ul>
The brand names of the estrogen therapy preparations carrying this risk include:<ul>
<li>CLIMARA (estradiol)</li> <li>ESTRACE (estradiol)</li>
<li>ESTRADERM (estradiol)</li>
<li>ESTRATAB (<a href="https://www.medicinenet.com/esterified_estrogens/article.htm" onclick="wmdTrack('embd-lnk');" rel="pharm">esterified estrogens</a>)</li> <li>ESTRATEST (esterified estrogens and methyltestosterone)</li>
<li>MENEST (esterified estrogens)</li> <li>OGEN (<a href="https://www.medicinenet.com/estropipate/article.htm" onclick="wmdTrack('embd-lnk');" rel="pharm">estropipate</a>)</li>
<li>PREMARIN (estrogens conjugated)</li>
<li>PREMPHASE (estrogens conjugated and medroxyprogesterone)</li>
<li>PREMPRO (estrogens conjugated and medroxyprogesterone)</li> </ul>
Cigarette smokers on estrogen therapy are at a higher risk than non-smokers for blood clots. Therefore, patients requiring estrogen therapy are strongly encouraged to quit <a href="https://www.medicinenet.com/smoking_and_quitting_smoking/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">smoking</a>.